Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-1,697
Closed -$77K – 5506
2020
Q2
$77K Hold
1,697
– – ﹤0.01% 4690
2020
Q1
$75K Sell
1,697
-99,116
-98% -$3.87M ﹤0.01% 4980
2019
Q4
$3.61M Buy
+100,813
New +$3.75M ﹤0.01% 2364
2019
Q2
– Sell
-14,146
Closed -$610K – 7202
2019
Q1
$610K Buy
+14,146
New +$569K ﹤0.01% 3930
2018
Q4
– Sell
-37,722
Closed -$1.52M – 7261
2018
Q3
$1.52M Buy
+37,722
New +$1.51M ﹤0.01% 3219

Other funds holding QGEN

Barclays's QGEN Position: Q3 2026 in Review

Barclays increased its Qiagen (QGEN) stake by 14% in Q3 2026, buying an estimated $8.67M and bringing the position to 1,637,950 shares worth $71.7M. The position accounts for 0.01% of the portfolio, ranked #640.

Barclays first reported a position in QGEN in Q1 2017 and has held it in 39 quarters since. The position peaked at $130M in Q4 2021. 366 funds tracked by Wall St. Rank hold QGEN as of Q3 2026.

  • Barclays held 1,637,950 shares of Qiagen worth $71.7M as of Q3 2026.
  • Barclays bought 204,387 Qiagen shares in Q3 2026, an estimated $8.67M.
  • Qiagen made up 0.01% of Barclays's portfolio in Q3 2026, its #640 holding.
  • Barclays first reported a position in Qiagen in Q1 2017 and has held it in 39 quarters since.
  • Barclays's Qiagen position peaked at $130M in Q4 2021.
  • 366 funds tracked by Wall St. Rank held Qiagen as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.